SYNTHESIS AND MUSCARINIC RECEPTOR ACTIVITY OF ESTER DERIVATIVES OF 2-SUBSTITUTED 2-AZABICYCLO[2.2.1]HEPTAN-5-OL AND 2-ABZABICYCLO[2.2.1]HEPTAN-6-OL

被引:16
作者
CARROLL, FI [1 ]
ABRAHAM, P [1 ]
CHEMBURKAR, S [1 ]
HE, XC [1 ]
MASCARELLA, SW [1 ]
KWON, YW [1 ]
TRIGGLE, DJ [1 ]
机构
[1] SUNY BUFFALO,SCH PHARM,DEPT BIOCHEM PHARMACOL,BUFFALO,NY 14260
关键词
D O I
10.1021/jm00090a006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Radioligand binding affinities of four new muscarinic antagonists and six potential muscarinic agonists which possess the 2-alkyl-2-azabicyclo[2.2.1]heptane ring system have been determined in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations to examine the selectivity for subtypes of muscarinic receptor. The efficacies of the potential muscarinic agonists were determined by the ratio of binding affinities against [H-3]QNB and [H-3]Oxo-M. Four muscarinic antagonists which have the 2,2-diphenylpropionate side chain at either the C-5 (5-endo or 5-exo) or the C6 (6-endo or 6-exo) positions did not discriminate between the subtypes of muscarinic receptors. The 2,2-diphenylpropionate 5-endo substituted compound was the most potent, showing affinities between 4.23 x 10(-10) and 1.18 x 10(-9) M in rat heart, rat brain, and m1- or m3-transfected CHO cell membrane preparations. The rank order of ester potency was 5-endo > 5-exo > 6-endo > 6-exo. A molecular modeling study based on the pharmacophore developed for azaprophen was used to account for the relative potency of these antagonists. Six potential muscarinic agonists which have acetoxy groups in the C, or C6 position with an N-methyl or N-benzyl substituent did not discriminate subtypes of muscarinic receptors and had affinities between 6.63 x 10(-6) and 4.76 x 10(-5) M in rat heart, rat brain, and m1- or M3-transfected CHO cell membrane preparations. exo-2-Methyl-5-acetoxy-2-azabicyclo[2.2.1] 2.2.1]heptane was the most efficacious partial agonist.
引用
收藏
页码:2184 / 2191
页数:8
相关论文
共 19 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]   CRYSTAL, SOLUTION, AND MOLECULAR MODELING STRUCTURAL-PROPERTIES AND MUSCARINIC ANTAGONIST ACTIVITY OF AZAPROPHEN [J].
CARROLL, FI ;
ABRAHAM, P ;
MASCARELLA, SW ;
SINGH, P ;
MORELAND, CG ;
SANKAR, SS ;
KWON, YW ;
TRIGGLE, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (04) :1436-1440
[3]   6-METHYL-6-AZABICYCLO[3.2.1]OCTAN-3-ALPHA-OL 2,2-DIPHENYLPROPIONATE (AZAPROPHEN), A HIGHLY POTENT ANTIMUSCARINIC AGENT [J].
CARROLL, FI ;
ABRAHAM, P ;
PARHAM, K ;
GRIFFITH, RC ;
AHMAD, A ;
RICHARD, MM ;
PADILLA, FN ;
WITKIN, JM ;
CHIANG, PK .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (05) :805-809
[4]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[5]  
FRASER CM, 1989, MOL PHARMACOL, V36, P840
[6]   RELATIVE AFFINITIES OF DRUGS ACTING AT CHOLINOCEPTORS IN DISPLACING AGONIST AND ANTAGONIST RADIOLIGANDS - THE NMS OXO-M RATIO AS AN INDEX OF EFFICACY AT CORTICAL MUSCARINIC RECEPTORS [J].
FREEDMAN, SB ;
HARLEY, EA ;
IVERSEN, LL .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) :437-445
[7]  
GIACOBINI E, 1988, CURRENT RES ALZHEIME
[8]   OXIDATION OF STERICALLY HINDERED ALCOHOLS TO CARBONYLS WITH DIMETHYL SULFOXIDE-TRIFLUOROACETIC ANHYDRIDE [J].
HUANG, SL ;
OMURA, K ;
SWERN, D .
JOURNAL OF ORGANIC CHEMISTRY, 1976, 41 (20) :3329-3331
[9]   MUSCARINIC RECEPTORS IN GUINEA-PIG ILEUM - A STUDY BY AGONIST - H-3-LABELED ANTAGONIST COMPETITION [J].
JIM, K ;
BOLGER, GT ;
TRIGGLE, DJ ;
LAMBRECHT, G .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (12) :1707-1714
[10]   AZA DIELS-ALDER REACTIONS IN AQUEOUS-SOLUTION - CYCLOCONDENSATION OF DIENES WITH SIMPLE IMINIUM SALTS GENERATED UNDER MANNICH CONDITIONS [J].
LARSEN, SD ;
GRIECO, PA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (06) :1768-1769